If you ask the average person what causes Alzheimer’s they’ll probably say ‘it’s in the genes’.
But despite what you may fear, in reality, experts say only about one in 100 cases of the memory robbing disease are caused by genes. In fact, about 80 per cent of Alzheimer’s cases are thought to be preventable.
That’s according to a group of 30 health experts across the US, UK, China and Japan, who believe we can reduce our risk of the
Eine revolutionäre Impfung, die toxische Proteine aus dem Gehirn entfernen soll, bevor sie den Schaden verursachen, der zur häufigsten Form der Demenz führt, wird derzeit an Patienten im Frühstadium der Krankheit getestet.
Wissenschaftler gehen davon aus, dass es nach Abschluss klinischer Studien innerhalb von fünf Jahren allgemein verfügbar sein könnte, um künftigen Generationen das Elend zu ersparen, an Alzheimer zu erkranken oder miterleben zu müssen, wie ihre Angehörigen langsam
Under extremely rare circumstances, it appears that Alzheimer’s disease can be transmitted between people. Five people who received contaminated injections of a growth hormone as children went on to develop Alzheimer’s unusually early, researchers report January 29 in Nature Medicine.
The findings represent “the first time iatrogenic Alzheimer’s disease has been described,” neurologist John Collinge said January 25 in a news briefing, referring to a disease caused by a medical procedure.
That sounds alarming, but researchers are quick to
A breakthrough new treatment for Alzheimer’s disease could ‘turn off’ the gene that helps cause the disease,
A new vaccine that appears to stop Alzheimer’s in its tracks is adding to optimism that this could be the beginning of the end for the disease.
A study of the jab in mice found that not only did the shot clear harmful amyloid plaque from the brain, it also prevented the behavioral changes that normally plague Alzheimer’s sufferers.
It comes after a year in which two breakthrough drugs proved they could slow the disease, ending decades of failed trials
Losing your sense of smell could be an early sign of Alzheimer’s disease — and memory and cognitive problems down the road.
This is the conclusion of researchers from Chicago who studied the olfactory capabilities of more than 850 people over the course of 15 years.
In particular, they focussed on the influence of a gene variant — known as APOE e4 — which is associated with the strongest risk of Alzheimer’s disease.
They found that, above the age of
They cost a ton, have major side effects, and there’s deep skepticism that they even work. So why are we pushing them on patients?
At the Alzheimer’s Association 2022 Walk to End Alzheimer’s on November 05, 2022, in Los Angeles. The group has enthusiastically backed new Alzheimer’s drugs, despite major scientific doubts about their efficacy.
(Maury Phillips / Getty Images for Alzheimer’s Association)
My father died of dementia. It was a long, slow decline that took almost a
Yet another new drug can temporarily hold off the mental decline caused by Alzheimer’s disease, scientists say.
The drug, called donanemab, slowed cognitive decline by about 35 percent over the course of a year and a half, according to data presented July 17 at the Alzheimer’s Association International Conference in Amsterdam and published the same day in JAMA.
The finding comes just weeks after the U.S. Food & Drug Administration gave full approval to another drug, called lecanemab (brand
It has already been heralded as the ‘turning point’ in the decades-long war against Alzheimer’s.
But questions about whether donanemab — and two similar drugs — are really the answer to combating the devastating disease remain unanswered.
Landmark trial findings published today revealed that donanemab, given as a once-monthly infusion, slowed the decline of Alzheimer’s by up to 60 per cent.
Patients in the earliest stages of the memory-robbing disease were spared from the inevitable worsening of their symptoms.
Pharmaceutical
People living with Alzheimer’s disease are likely going to require a great deal of care.
How much they rely on others to perform daily tasks for them will depend on the severity of symptoms, on when the disease is diagnosed, on age and more.
Caring for a loved one with Alzheimer’s can be difficult for a number of reasons.
An initial diagnosis for both the patient and their loved ones is likely both shocking and painful. Sometimes, preparing for the
